ISSN: 2529-9123

Clínica e Investigación en Arteriosclerosis is the official journal of the Spanish Society of Arteriosclerosis, the Latinoamerican Society of Arteriosclerosis and the Iberolatinoamerican Society of Arteriosclerosis. The journal is the leading Spanish written peer-review journal in the field of arteriosclerosis and its related risk factors. The aim of the journal is primarily the promotion of knowledge and continued medical education, with a special focus in the Spanish-speaking audience, through the publication of relevant research contributions, basic and clinical, in the field and the publication of review and update articles.

See more Open Access Option

Clínica e Investigación en Arteriosclerosis has received its first journal Impact Factor (JCR) in 2023. Instructions for authors - Submit an article

"Methodological Notes": a new and important section in Clínica e Investigación en Arteriosclerosis

Indexed in:

Web of Science, Index Medicus/MEDLINE, Scopus, IBECS, IME, MEDES

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2022

1.6

Citescore

CiteScore measures average citations received per document published.

Citescore 2022

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2022

0.36

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2022

0.605

View more metrics

Journal Information

Back to article

Statistics

Follow this link to access the full text of the article

Original article

Prevalence rates of overweight and obesity and their associations with cardiometabolic and renal factors. SIMETAP-OB study

Tasas de prevalencia de sobrepeso y obesidad y sus asociaciones con factores cardiometabólicos y renales. Estudio SIMETAP-OB

Antonio Ruiz-Garcíaa,

Corresponding author

antoniodoctor@gmail.com

Corresponding author.

, Ezequiel Arranz-Martínezb, Luis Enrique Morales-Cobosc, Juan Carlos García-Álvarezd, Nerea Iturmendi-Martíneze, Montserrat Rivera-Teijidof, on behalf of the Grupo de Investigación del Estudio SIMETAP

a Lipids and Cardiovascular Prevention Unit, Pinto University Health Center, Pinto, Madrid, Spain

b San Blas Health Center, Parla, Madrid, Spain

c Las Américas University Health Center, Parla, Madrid, Spain

d Dr. Mendiguchía-Carriche Health Center, Leganés, Madrid, Spain

e Argüelles Health Center, Madrid, Spain

f Alicante Health Center, Fuenlabrada, Madrid, Spain

Read

363

Times
was read the article

Total PDF

328

Total HTML